Sema4, spun out of Icahn School of Medicine, has achieved a valuation of more than $1bn following a $121m series C round.
Sema4, a US-based health information spinout from integrated health system Mount Sinai Health System, yesterday raised $121m in a series C round led by investment management company BlackRock.
Deerfield Management Company, Moore Strategic Ventures, Blackstone, Section 32, Oak HC/FT, Decheng Capital and Connecticut Innovations also took part in the round, which valued Sema4 at more than $1bn post-money.
Sema4 provides screening services to help diagnose, treat and prevent disease. The company initially focused on producing models for reproductive…
